Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Gains from Investment Securities (2020 - 2025)

Historic Gains from Investment Securities for KORU Medical Systems (KRMD) over the last 11 years, with Q3 2025 value amounting to $27626.0.

  • KORU Medical Systems' Gains from Investment Securities rose 31.59% to $27626.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $108139.0, marking a year-over-year decrease of 6.28%. This contributed to the annual value of $107963.0 for FY2024, which is 805.38% up from last year.
  • As of Q3 2025, KORU Medical Systems' Gains from Investment Securities stood at $27626.0, which was up 31.59% from $27249.0 recorded in Q2 2025.
  • In the past 5 years, KORU Medical Systems' Gains from Investment Securities registered a high of $3.6 million during Q1 2022, and its lowest value of -$56279.0 during Q1 2023.
  • Over the past 5 years, KORU Medical Systems' median Gains from Investment Securities value was $26821.0 (recorded in 2024), while the average stood at $230646.1.
  • In the last 5 years, KORU Medical Systems' Gains from Investment Securities surged by 42798823.53% in 2022 and then plummeted by 10154.67% in 2023.
  • Quarter analysis of 5 years shows KORU Medical Systems' Gains from Investment Securities stood at $414.0 in 2021, then surged by 6370.53% to $26788.0 in 2022, then decreased by 0.43% to $26673.0 in 2023, then dropped by 0.91% to $26429.0 in 2024, then grew by 4.53% to $27626.0 in 2025.
  • Its Gains from Investment Securities was $27626.0 in Q3 2025, compared to $27249.0 in Q2 2025 and $26835.0 in Q1 2025.